Barhemsys amisulpride

Despite manufacturing concern, Acacia still expects 1H19 launch for PONV therapy
BioCentury
Mon, 10/8/18 - 11:40 pm
Acacia Pharma
Barhemsys amisulpride
post-operative nausea and vomiting
PONV